[Antibiotic cover during antineoplastic therapy].
D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000009:adverse effects; D001424:Bacterial Infections / Q000188:drug therapy; D004927:Escherichia coli Infections / Q000188:drug therapy; D006801:Humans; D007239:Infections / Q000188:drug therapy* / Q000209:etiology; D007410:Intestinal Diseases / Q000188:drug therapy; D007710:Klebsiella Infections / Q000188:drug therapy; D009181:Mycoses / Q000209:etiology; D009369:Neoplasms / Q000150:complications* / Q000188:drug therapy; D011512:Proteus Infections / Q000188:drug therapy; D011552:Pseudomonas Infections / Q000188:drug therapy; D012141:Respiratory Tract Infections / Q000188:drug therapy; D018805:Sepsis / Q000188:drug therapy; D013203:Staphylococcal Infections / Q000188:drug therapy; D013449:Sulfonamides / Q000627:therapeutic use; D014552:Urinary Tract Infections / Q000188:drug therapy
D000900:Anti-Bacterial Agents; D000970:Antineoplastic Agents; D013449:Sulfonamides
La protezione antibiotica nel corso delle terapie antiblastiche.